Enhanced anti-melanoma efficacy through a combination of the armed oncolytic adenovirus ZD55-IL-24 and immune checkpoint blockade in B16-bearing immunocompetent mouse model.
Saved in:
| Title: | Enhanced anti-melanoma efficacy through a combination of the armed oncolytic adenovirus ZD55-IL-24 and immune checkpoint blockade in B16-bearing immunocompetent mouse model. |
|---|---|
| Authors: | Hu HJ; State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, 200031, China. huhaijun2015@sibcb.ac.cn.; University of Chinese Academy of Sciences, Beijing, 100049, China. huhaijun2015@sibcb.ac.cn., Liang X; School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China., Li HL; Department of Pharmacy, Xiamen Medical College, Xiamen, 361023, China., Wang HY; State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, 200031, China.; University of Chinese Academy of Sciences, Beijing, 100049, China., Gu JF; State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, 200031, China., Sun LY; State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, 200031, China., Xiao J; State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, 200031, China.; University of Chinese Academy of Sciences, Beijing, 100049, China., Hu JQ; State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, 200031, China., Ni AM; State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, 200031, China. aimin.ni@sibcb.ac.cn., Liu XY; State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, 200031, China. xyliu@sibcb.ac.cn. |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2021 Dec; Vol. 70 (12), pp. 3541-3555. Date of Electronic Publication: 2021 Apr 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33903973 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Enhanced anti-melanoma efficacy through a combination of the armed oncolytic adenovirus ZD55-IL-24 and immune checkpoint blockade in B16-bearing immunocompetent mouse model. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hu+HJ%22">Hu HJ</searchLink>; State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, 200031, China. huhaijun2015@sibcb.ac.cn.; University of Chinese Academy of Sciences, Beijing, 100049, China. huhaijun2015@sibcb.ac.cn.<br /><searchLink fieldCode="AU" term="%22Liang+X%22">Liang X</searchLink>; School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China.<br /><searchLink fieldCode="AU" term="%22Li+HL%22">Li HL</searchLink>; Department of Pharmacy, Xiamen Medical College, Xiamen, 361023, China.<br /><searchLink fieldCode="AU" term="%22Wang+HY%22">Wang HY</searchLink>; State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, 200031, China.; University of Chinese Academy of Sciences, Beijing, 100049, China.<br /><searchLink fieldCode="AU" term="%22Gu+JF%22">Gu JF</searchLink>; State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, 200031, China.<br /><searchLink fieldCode="AU" term="%22Sun+LY%22">Sun LY</searchLink>; State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, 200031, China.<br /><searchLink fieldCode="AU" term="%22Xiao+J%22">Xiao J</searchLink>; State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, 200031, China.; University of Chinese Academy of Sciences, Beijing, 100049, China.<br /><searchLink fieldCode="AU" term="%22Hu+JQ%22">Hu JQ</searchLink>; State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, 200031, China.<br /><searchLink fieldCode="AU" term="%22Ni+AM%22">Ni AM</searchLink>; State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, 200031, China. aimin.ni@sibcb.ac.cn.<br /><searchLink fieldCode="AU" term="%22Liu+XY%22">Liu XY</searchLink>; State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, 200031, China. xyliu@sibcb.ac.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228605732%22">Cancer immunology, immunotherapy : CII</searchLink> [Cancer Immunol Immunother] 2021 Dec; Vol. 70 (12), pp. 3541-3555. <i>Date of Electronic Publication: </i>2021 Apr 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8605732 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0851 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203407004%22">03407004 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Immunother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33903973 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00262-021-02946-z Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3541 Titles: – TitleFull: Enhanced anti-melanoma efficacy through a combination of the armed oncolytic adenovirus ZD55-IL-24 and immune checkpoint blockade in B16-bearing immunocompetent mouse model. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hu HJ – PersonEntity: Name: NameFull: Liang X – PersonEntity: Name: NameFull: Li HL – PersonEntity: Name: NameFull: Wang HY – PersonEntity: Name: NameFull: Gu JF – PersonEntity: Name: NameFull: Sun LY – PersonEntity: Name: NameFull: Xiao J – PersonEntity: Name: NameFull: Hu JQ – PersonEntity: Name: NameFull: Ni AM – PersonEntity: Name: NameFull: Liu XY IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2021 Dec Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1432-0851 Numbering: – Type: volume Value: 70 – Type: issue Value: 12 Titles: – TitleFull: Cancer immunology, immunotherapy : CII Type: main |
| ResultId | 1 |
